Blume Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Blume Capital Management's MDT Position: Q2 2026 in Review
Blume Capital Management increased its Medtronic (MDT) stake by 6,705% in Q2 2026, buying an estimated $1.62M and bringing the position to 20,414 shares worth $1.6M. The position accounts for 0.23% of the portfolio, ranked #71.
Blume Capital Management first reported a position in MDT in Q4 2013 and has held it in 27 quarters since. The position peaked at $1.85M in Q3 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Blume Capital Management held 20,414 shares of Medtronic worth $1.6M as of Q2 2026.
- Blume Capital Management bought 20,114 Medtronic shares in Q2 2026, an estimated $1.62M.
- Medtronic made up 0.23% of Blume Capital Management's portfolio in Q2 2026, its #71 holding.
- Blume Capital Management first reported a position in Medtronic in Q4 2013 and has held it in 27 quarters since.
- Blume Capital Management's Medtronic position peaked at $1.85M in Q3 2024.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.